Companies: 10,795·Total market cap: $144.5T
NeuroPace, Inc.

NeuroPace, Inc.

NPCENASDAQHealthcare● Active
$15.67
$-0.08(-0.48%)
Market Cap$534078515
P/E Ratio
52W High$19.6
52W Low$7.563
Overview

NeuroPace, Inc. (NPCE) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

npce · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 10 Wall Street analysts in the past 3 months

SellBuy

Buy

10 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
9
Hold
1
Sell
0
Strong Sell
0
Total: 10 · Buy rate: 90.0%

12-Month Price Target

High

$22.00

Consensus

$21.00

+34.0% upside

Low

$20.00

Median: $21 · Last Close: $15.68

The NeuroPace, Inc. (NPCE) analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month NPCE price target is $21.00, representing +34.0% upside from the current price of $15.68.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $21 (34.0%)

Consensus Target

$21.00

34.0% upside

High Target

$22

40.4%

Low Target

$20

27.6%

Current Price

$15.68

as of today

Based on analyst price targets, the NPCE stock price prediction for the next 12 months ranges from $20 to $22. The consensus NPCE price forecast of $21.00 implies 34.0% upside from the current price of $15.68.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$15.540.87%

1-day model range: $15.43–$15.65. Peak: $15.65 (-0.87%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$25+58.9%
2028$33+110.4%
2029$39+147.9%
2030$43+172.2%
2031+186.8%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

29%7%64%
4Buy
1Neutral
9Sell
RSI (14)46.7Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NPCE · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$15.98SELL
MA 10$16.41SELL
MA 20$16.19SELL
MA 50$16.00SELL
MA 100$15.45BUY
MA 200$14.01BUY
Current $NPCE · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$15.98SELL
EMA 10$16.19SELL
EMA 20$16.30SELL
EMA 50$16.02SELL
EMA 100$15.45BUY
EMA 200$14.41BUY
Current $NPCE · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-05-15
Maintains
BuyBuy
HC Wainwright & Co.2026-01-27
Maintains
BuyBuy
UBS2025-12-16
Maintains
BuyBuy
JP Morgan2025-12-10
Maintains
OverweightOverweight
JP Morgan2025-11-05
Maintains
OverweightOverweight
Wells Fargo2025-11-05
Maintains
OverweightOverweight
Wells Fargo2025-08-13
Maintains
OverweightOverweight
JP Morgan2025-05-14
Maintains
OverweightOverweight
Cantor Fitzgerald2025-05-14
Maintains
OverweightOverweight
Cantor Fitzgerald2025-04-14
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on NeuroPace, Inc. (NPCE) stock. Of the recent 48 rating actions, 2 were upgrades and 2 were downgrades. 10 analysts currently cover NPCE.

Analyst Recommendation Trends

Buy ratings211
Hold ratings00
Sell ratings00

NPCE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$100M

↓ 34.8% YoY

Revenue Next Year

$123M

↑ 23.3% YoY

EPS This Year

$-0.58

EPS Next Year

$-0.30

↓ 47.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NPCE EPS of $-0.58 for the current fiscal year, based on estimates from 6 analysts. The NPCE revenue forecast is $100M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The NPCE stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NPCE price target is $21.00 (+34.0% upside), with an analyst consensus of Buy.

The NPCE short-term stock prediction for tomorrow is $15.54 (-0.87%). The NPCE stock price prediction for 2027 estimates an average of $25. The NPCE stock prediction for 2030 projects a range of $39–$46.

NeuroPace, Inc. trades on NASDAQ under the ticker NPCE. The NPCE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 90% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

NPCE forecast · 8 questions

According to 10 Wall Street analysts, the average 12-month NPCE price target is $21.00, with a high forecast of $22.00 and a low of $20.00. The median price target is shown in the chart above when available. This implies +34.0% potential upside from the current price of $15.68.

NPCE price targetWhat is NPCE price targetNPCE analyst price targetNPCE 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.